Merck & Co., Inc. (NYSE:MRK) Given New $135.00 Price Target at JPMorgan Chase & Co.

Merck & Co., Inc. (NYSE:MRK) Given New $135.00 Price Target at JPMorgan Chase & Co.

Merck & Co., Inc. (NYSE:MRK – Free Report) had its price objective upped by JPMorgan Chase & Co. from $125.00 to $135.00 in a report issued on Monday,Benzinga reports. They currently have an overweight rating on the stock. MRK has been the topic of a number of other research reports. Wells Fargo & Company boosted their price objective on shares of Merck & Co., Inc. from $135.00 to $150.00 and gave the company an “overweight” rating in a research…